Elite Pharmaceuticals (OTCMKTS:ELTP) Issues Earnings Results

Key Points

• Elite Pharmaceuticals reported earnings of ($0.01) earnings per share (EPS) for the quarter, with a negative net margin of 5.13% and a positive return on equity of 3.96%.
• The company's stock remained flat at $0.53 during midday trading, with a trading volume of 1,195,490 shares.
• Elite Pharmaceuticals specializes in the development, manufacture, and sale of oral, controlled-release products and generic pharmaceuticals, operating under two main segments.

Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) issued its earnings results on Thursday. The specialty pharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. Elite Pharmaceuticals had a negative net margin of 5.13% and a positive return on equity of 3.96%.

Elite Pharmaceuticals Stock Down 0.0%

Elite Pharmaceuticals stock traded down $0.00 during midday trading on Thursday, reaching $0.53. 1,195,490 shares of the company were exchanged, compared to its average volume of 1,212,084. The company has a current ratio of 4.88, a quick ratio of 3.50 and a debt-to-equity ratio of 0.08. The firm's 50-day simple moving average is $0.61 and its 200-day simple moving average is $0.51. Elite Pharmaceuticals has a 1 year low of $0.18 and a 1 year high of $0.82.

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.